Author

A. Allwardt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Pan· 1 shared B. Quinlan· 1 shared C. Bailey· 1 shared D. Mitra· 1 shared H. Choe· 1 shared M. Farzan· 1 shared N. Bronkema· 1 shared N. Skamangas· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Pan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates

W. He, T. Ou, N. Skamangas, C. Bailey, N. Bronkema, Y. Guo, Y. Yin, V. Kobzarenko, X. Zhang, A. Pan, X. Liu, A. Allwardt, D. Mitra, B. Quinlan, R. Sanders, , M. Farzan

The paper evaluates HIV-1 vaccine candidates using HCDR3-engineered B cells, finding that SOSIP-TM mRNA-lipid nanoparticles induce stronger anti-apex responses than multimerized SOSIP proteins.

bioRxiv · Nov 7, 2022 · PreprintImmunology